MAIT cells are activated during human viral infections

Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson, +52

Nature Communications

Steatosis affects chronic hepatitis C progression in a genotype specific way

Laura Rubbia‐Brandt, Paolo Fabris, S. Paganin, +7

Gut

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Luca Arcaini, Caroline Besson, Marco Frigeni, +22

Blood

Identification of a novel variant of hepatitis E virus in Italy

Alessandro Zanetti, George G. Schlauder, Luisa Roman�, +4

Journal of Medical Virology

Impact of HIV on Host‐Virus Interactions during Early Hepatitis C Virus Infection

Mark Danta, Nasser Semmo, Paolo Fabris, +7

The Journal of Infectious Diseases

Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy

T. Santantonio, Emanuela Medda, Carlo Ferrari, +12

Clinical Infectious Diseases

Randomized Prospective Controlled Trial of Recombinant Granulocyte Colony-Stimulating Factor as Adjunctive Therapy for Limb-Threatening Diabetic Foot Infection

Fausto de Lalla, Giampietro Pellizzer, Marco Strazzabosco, +6

Antimicrobial Agents and Chemotherapy

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Elisabetta Degasperi, Angiola Spinetti, Andrea Lombardi, +31

Journal of Hepatology

HepatologyHepatitis CViral HepatitisHepatitis C PatientsReal-life Effectiveness +6

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Alessandro Grasso, Federica Malfatti, Pasqualina De Leo, +5

Journal of Hepatology

Insulin ResistanceHcv PatientsHepatologyViral HepatitisDiabetes +7

Changing Epidemiology of HCV and HBV Infections in Northern Italy

Paolo Fabris, Vincenzo Baldo, Tatjana Baldovin, +6

Journal of Clinical Gastroenterology